Revospirone
Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquilizer but was never marketed. It acts as a selective 5-HT1A receptor partial agonist. Similarly to other azapirones such as buspirone, revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite. As a result, it also acts as an α2-adrenergic receptor antagonist to an extent.
Wikipage redirect
primaryTopic
Revospirone
Revospirone (Bay Vq 7813) is an azapirone drug which was patented as a veterinary tranquilizer but was never marketed. It acts as a selective 5-HT1A receptor partial agonist. Similarly to other azapirones such as buspirone, revospirone produces 1-(2-pyrimidinyl)piperazine (1-PP) as an active metabolite. As a result, it also acts as an α2-adrenergic receptor antagonist to an extent.
has abstract
Revospirone (Bay Vq 7813) is a ...... eptor antagonist to an extent.
@en
ATC prefix
CAS number
95847-87-3
FDA UNII code
6X8764TW2J
IUPAC name
1,1-dioxo-2-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propyl]-1,2-benzothiazol-3-one
@en
PubChem
thumbnail
Wikipage page ID
26,466,154
Wikipage revision ID
744,598,205
ChemSpiderID
molecular weight
hypernym
comment
Revospirone (Bay Vq 7813) is a ...... eptor antagonist to an extent.
@en
label
Revospirone
@en